Immune checkpoint inhibitors in malignant pleural mesothelioma
Lancet Oncol
.
2017 May;18(5):559-561.
doi: 10.1016/S1470-2045(17)30191-2.
Authors
Giovanni Luca Ceresoli
1
,
Alberto Mantovani
2
Affiliations
1
Thoracic and GU Oncology Unit, Department of Medical Oncology, Cliniche Humanitas Gavazzeni, 24125 Bergamo, Italy. Electronic address: giovanni_luca.ceresoli@gavazzeni.it.
2
Humanitas University, Istituto Clinico Humanitas IRCCS, Milan, Italy.
PMID:
28495276
DOI:
10.1016/S1470-2045(17)30191-2
No abstract available
Publication types
Comment
MeSH terms
Humans
Lung Neoplasms*
Mesothelioma*
Pleural Neoplasms